{"id":"https://openalex.org/W28777286","doi":null,"title":"Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.","display_name":"Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W28777286","mag":"28777286","pmid":"https://pubmed.ncbi.nlm.nih.gov/2698483"},"language":"en","primary_location":{"id":"pmid:2698483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2698483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087258120","display_name":"Bruce Parsons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Parsons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009644987","display_name":"Frederic M. Quitkin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F M Quitkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001996205","display_name":"Patrick J. McGrath","orcid":"https://orcid.org/0000-0002-9568-2571","observed_orcids":["https://orcid.org/0000-0002-9568-2571"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J McGrath","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026006129","display_name":"Jonathan W. Stewart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J W Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062723911","display_name":"ELAINE TRICAMO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Tricamo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001119127","display_name":"Katja Ocepek\u2010Welikson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Ocepek-Welikson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045886451","display_name":"Wilma M. Harrison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Harrison","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043752425","display_name":"Judith G. Rabkin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J G Rabkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060185501","display_name":"S G Wager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S G Wager","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"E Nunes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Nunes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5744,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.81122684,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"25","issue":"4","first_page":"524","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11093","display_name":"Personality Disorders and Psychopathology","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11093","display_name":"Personality Disorders and Psychopathology","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenelzine","display_name":"phenelzine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.996999979019165},{"id":"https://openalex.org/keywords/atypical-depression","display_name":"atypical depression","score":0.9120000004768372},{"id":"https://openalex.org/keywords/borderline-personality-disorder","display_name":"borderline personality disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/schizotypal-personality-disorder","display_name":"schizotypal personality disorder","score":0.7789999842643738},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.824999988079071},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9570000171661377},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.8050000071525574},{"id":"https://openalex.org/keywords/dysthymia","display_name":"dysthymia","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2781073023","wikidata":"https://www.wikidata.org/wiki/Q1747559","display_name":"Phenelzine","level":4,"score":0.9021687507629395},{"id":"https://openalex.org/C2780600973","wikidata":"https://www.wikidata.org/wiki/Q2712836","display_name":"Borderline personality disorder","level":2,"score":0.8314230442047119},{"id":"https://openalex.org/C2776571617","wikidata":"https://www.wikidata.org/wiki/Q2657784","display_name":"Atypical depression","level":3,"score":0.7608652114868164},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5450471043586731},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.5286467671394348},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5277413129806519},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5083515048027039},{"id":"https://openalex.org/C2778630814","wikidata":"https://www.wikidata.org/wiki/Q410954","display_name":"Monoamine oxidase inhibitor","level":4,"score":0.49214619398117065},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.48094505071640015},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4775839149951935},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.46836909651756287},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4618507921695709},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4523972272872925},{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.4432927966117859},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4134521782398224},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4095335006713867},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2371424436569214},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11888563632965088},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001883","descriptor_name":"Borderline Personality Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010624","descriptor_name":"Phenelzine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2698483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2698483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},{"id":"mag:28777286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2698483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2402676502","https://openalex.org/W2992000455","https://openalex.org/W78097575","https://openalex.org/W2467451715","https://openalex.org/W2111287604","https://openalex.org/W127024954","https://openalex.org/W2490230832","https://openalex.org/W2108925817","https://openalex.org/W2059579292","https://openalex.org/W3028174568"],"abstract_inverted_index":{"In":[0],"planning":[1],"psychopharmacologic":[2],"treatment":[3,108],"of":[4,20,42,53],"patients":[5,79,114],"with":[6,109,115,124,133],"borderline":[7,82,120],"personality":[8],"disorder":[9,46],"(BPD),":[10],"three":[11],"partially":[12],"validated":[13],"subtypes":[14],"should":[15],"be":[16],"considered.":[17],"The":[18,40,70],"validity":[19,41],"the":[21,51,134],"schizotypal":[22],"subtype":[23],"is":[24,48],"supported":[25,49],"by":[26,35,50],"their":[27,57,63],"favorable":[28],"response":[29,59,65],"to":[30,60,66],"neuroleptics":[31],"as":[32,34],"well":[33],"familial":[36],"and":[37,62,68,84,101],"genetic":[38],"studies.":[39],"emotionally":[43],"unstable":[44],"character":[45],"(EUCD)":[47],"presence":[52],"neurological":[54],"soft":[55],"signs,":[56],"negative":[58],"antidepressants,":[61],"positive":[64],"chlorpromazine":[67],"lithium.":[69],"data":[71],"presented":[72],"in":[73],"this":[74],"paper":[75],"suggest":[76],"that":[77],"some":[78,113],"who":[80,97,118],"meet":[81,119],"criteria":[83,91,121],"have":[85,98],"atypical":[86,103,116],"depression":[87,94,117],"(patients":[88],"meeting":[89],"DSM-III-R":[90],"for":[92],"major":[93],"or":[95],"dysthymia":[96],"reactive":[99],"mood":[100],"any":[102],"symptoms)":[104],"clearly":[105],"benefit":[106],"from":[107],"antidepressant":[110],"medication.":[111],"Although":[112],"will":[122,131],"improve":[123,132],"tricyclic":[125],"therapy,":[126],"a":[127],"significantly":[128],"greater":[129],"proportion":[130],"monoamine":[135],"oxidase":[136],"inhibitor":[137],"(MAOI),":[138],"phenelzine.":[139]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}